From Test to Treatment: Unlocking the Power of Precision Medicine
29th September 2025
10:30 – 11:45
Room 1C, ACC Liverpool
With rapid advancements in genetic testing, genomic medicine, and precision therapies, the promise of personalised healthcare is closer than ever. But who gets access, and how?
This panel will explore the challenges of delivering these innovations equitably. We will ask what needs to happen across research, regulation, and clinical delivery to ensure that individuals with rare and inherited conditions – such as specific forms of motor neurone disease – can access timely, targeted care.
Partners
Speakers
Matilda Martin
Reporter
PoliticsHome
Tanya Curry
CEO
MND Association
Louise Fish
Chair
NHS England’s Rare Diseases Advisory Group
Marc Barlow
Person living with MND and Trustee
Peter Dowd MP
MP for Bootle
Chair, Genetic, Rare and Undiagnosed Conditions APPG
Name Surname MP
Shadow Minister for Skills and Further Education
Sed haec quis possit intrepidus aestimare tellus. Tityre, tu patulae recubans sub tegmine fagi dolor. Me non paenitet nullum festiviorem excogitasse ad hoc. Quo usque tandem abutere, Catilina, patientia nostra? Ambitioni dedisse scripsisse iudicaretur.
A communi observantia non est recedendum. Phasellus laoreet lorem vel dolor tempus vehicula. Unam incolunt Belgae, aliam Aquitani, tertiam. Quam diu etiam furor iste tuus nos eludet? Morbi odio eros, volutpat ut pharetra vitae, lobortis sed nibh. Gallia est omnis divisa in partes tres, quarum.